Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORE(SM) Registry

INTRODUCTION: The aim of this study was to evaluate the clinical outcomes and safety of daptomycin therapy in patients with serious Gram-positive infections. METHODS: Patients were enrolled in the European Cubicin(®) Outcomes Registry and Experience (EU-CORE(SM)), a non-interventional, multicenter,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gonzalez-Ruiz, Armando, Gargalianos-Kakolyris, Panayiotis, Timerman, Artur, Sarma, Jayanta, José González Ramallo, Víctor, Bouylout, Kamel, Trostmann, Uwe, Pathan, Rashidkhan, Hamed, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486780/
https://www.ncbi.nlm.nih.gov/pubmed/26108157
http://dx.doi.org/10.1007/s12325-015-0220-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4486780/
https://www.ncbi.nlm.nih.gov/pubmed/26108157
http://dx.doi.org/10.1007/s12325-015-0220-6

Ejemplares similares